NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand
about
Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite thRecognition and Regulation of T Cells by NK CellsA New Scientific Paradigm may be Needed to Finally Develop an HIV VaccineEvasion from NK cell-mediated immune responses by HIV-1Perspectives for immunotherapy: which applications might achieve an HIV functional cure?Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutininViremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and functionHIV-1 and hijacking of the host immune system: the current scenario.Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44.Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44.HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway.Higher Expression of Activating Receptors on Cytotoxic NK Cells is Associated with Early Control on HIV-1C Multiplication.Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands.Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy.Challenges in HIV Vaccine Research for Treatment and Prevention.Innate immune activation in primary HIV-1 infection.Th17 and regulatory T cells: implications for AIDS pathogenesisNK cells and their ability to modulate T cells during virus infectionsNatural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.An acidic microenvironment increases NK cell killing of Cryptococcus neoformans and Cryptococcus gattii by enhancing perforin degranulation.HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivoNK cell activation in human hantavirus infection explained by virus-induced IL-15/IL15Rα expression.The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells.DCs and NK cells: critical effectors in the immune response to HIV-1.HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicityHIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blastsLysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D.Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.Natural cytotoxicity receptor splice variants orchestrate the distinct functions of human natural killer cell subtypes.Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells.Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaquesAccumulation of Intrahepatic TNF-α-Producing NKp44+ NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV InfectionNatural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulationNKp44 expression, phylogenesis and function in non-human primate NK cells.Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination.Natural killer cells in immunodefense against infective agents.Identification of the gC1qR sites for the HIV-1 viral envelope protein gp41 and the HCV core protein: Implications in viral-specific pathogenesis and therapy.The modulation of the cell-cycle: a sentinel to alert the NK cells of dangers.
P2860
Q24671809-ACA41552-2671-4D55-ACDE-CA08D4A23026Q26742166-9B1F2B69-136E-4F18-AA13-D5964601BEBFQ26830360-6D5EEFC2-FB3B-4EFB-B3C6-5AB51BB3D237Q26864489-B63D46C1-2EA1-44BA-9546-880D3DE22907Q28078726-7FF9E6B8-65A4-4073-A385-DBC1998CE29BQ28476707-B6695076-C8A2-478A-9F9A-DB547A7C8516Q28732293-F9F5B266-BE33-41AA-A455-06C9552FD8C5Q30248405-4742F59B-A698-4B64-9F29-D2C19D5CE033Q30845033-6ABB375E-D75E-430D-8502-05698B64F456Q33292470-5FFDCCC6-C6D8-42CF-8885-5D64783C0147Q33311287-1660AB53-6479-44ED-86D4-FD1A7E3DB59DQ33628767-5FBA13E1-691B-45F9-B246-981E6BAD2105Q33657935-DE0DDFB4-5240-4E5C-8521-97BED3D75BC2Q33828392-25E712B1-9DB2-40EF-999B-359D5654BC95Q34126743-4B1CDA4D-500C-4C76-BD90-0ED1086AB89BQ34148683-66436DA1-7CDD-44E8-B7FF-569590A1D478Q34155538-72E0F7F2-4444-4BC4-BE2B-F85F22C1E5C8Q34395054-B968D900-8DAF-4213-8F34-3F44EE8978E6Q34700499-8D0A25E4-51A3-4F87-AA5B-02184A323D62Q34741864-F4CD224F-4805-4BEA-9DD0-3B5E3B933757Q34819510-F479872E-50BA-4D8D-91E9-97CB45A034E5Q35067233-3FEA0FD2-A591-4960-B5F2-259164D71E02Q35439923-23D5A838-F93F-4F30-BC40-EF026B67CF37Q35640941-00F06923-71A1-415E-BBF8-C35CFECD3C99Q35752667-23126F34-F7C9-4C65-9051-ECADE399C3B4Q35868113-9907846E-4EF6-443E-8740-E6C888EACABFQ35925041-3CB503A2-28F8-41F4-91C4-2C0999E49B49Q36064034-3E2587B8-88A5-43F5-9F5E-84F43B43EDF7Q36229197-0FB0DD7C-83A5-4770-B258-7F25E140E498Q36379601-727698C9-CB84-4AA3-8DF8-E639BA501A27Q36701917-7D30C75A-66A2-4F0C-BBFB-CC24916F1492Q36747731-D18C663F-CE1B-407C-B293-DF852C74D61BQ36890919-A7F812B4-F0C8-45B3-91C2-6A74B496B51DQ36993610-54B3FF6E-A68E-4BE5-9791-6939C0F275D5Q37031810-0D485D3A-360D-4414-B85A-DF957A428FA5Q37104639-04D4438F-3B24-4B08-A161-6B40D4F49280Q37128257-2F370A45-487F-47C8-A28C-5973261124F6Q37178929-B9D86E8A-C47C-4D6B-946A-070A63092338Q37180378-D7B26D84-3787-495C-B050-9D37E64EEE67Q37218039-F09A02E0-A683-44D9-A1F9-93916D565E5A
P2860
NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
NK cytotoxicity against CD4+ T ...... expression of an NKp44 ligand
@ast
NK cytotoxicity against CD4+ T ...... expression of an NKp44 ligand
@en
type
label
NK cytotoxicity against CD4+ T ...... expression of an NKp44 ligand
@ast
NK cytotoxicity against CD4+ T ...... expression of an NKp44 ligand
@en
prefLabel
NK cytotoxicity against CD4+ T ...... expression of an NKp44 ligand
@ast
NK cytotoxicity against CD4+ T ...... expression of an NKp44 ligand
@en
P2860
P356
P1476
NK cytotoxicity against CD4+ T ...... expression of an NKp44 ligand
@en
P2093
Jack L Strominger
Vincent Vieillard
P2860
P304
10981-10986
P356
10.1073/PNAS.0504315102
P407
P577
2005-07-26T00:00:00Z